Concepts (97)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Inflammatory Bowel Diseases | 3 | 2023 | 110 | 1.700 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2023 | 50 | 0.750 |
Why?
|
| Herpes Zoster Vaccine | 1 | 2022 | 1 | 0.750 |
Why?
|
| Influenza Vaccines | 1 | 2022 | 100 | 0.680 |
Why?
|
| Weight Reduction Programs | 1 | 2019 | 63 | 0.550 |
Why?
|
| Antifungal Agents | 4 | 2012 | 125 | 0.530 |
Why?
|
| Vaccination | 2 | 2022 | 388 | 0.490 |
Why?
|
| Weight Loss | 1 | 2019 | 276 | 0.490 |
Why?
|
| Immunosuppressive Agents | 2 | 2014 | 382 | 0.460 |
Why?
|
| Fungi | 2 | 2012 | 57 | 0.430 |
Why?
|
| Bell Palsy | 1 | 2014 | 5 | 0.430 |
Why?
|
| Moths | 1 | 2014 | 27 | 0.420 |
Why?
|
| Viral Vaccines | 1 | 2014 | 56 | 0.410 |
Why?
|
| Virulence Factors | 1 | 2014 | 86 | 0.410 |
Why?
|
| Bacterial Vaccines | 1 | 2014 | 79 | 0.400 |
Why?
|
| Virus Diseases | 1 | 2014 | 118 | 0.390 |
Why?
|
| Cryptococcus neoformans | 1 | 2014 | 142 | 0.380 |
Why?
|
| Crohn Disease | 1 | 2014 | 108 | 0.380 |
Why?
|
| Bacterial Infections | 1 | 2014 | 151 | 0.380 |
Why?
|
| Cryptococcus | 1 | 2012 | 13 | 0.360 |
Why?
|
| Meningitis, Cryptococcal | 1 | 2012 | 14 | 0.360 |
Why?
|
| Invertebrates | 1 | 2012 | 19 | 0.360 |
Why?
|
| Caenorhabditis elegans | 2 | 2018 | 709 | 0.340 |
Why?
|
| Disease Models, Animal | 3 | 2018 | 2329 | 0.290 |
Why?
|
| Retrospective Studies | 6 | 2023 | 6957 | 0.190 |
Why?
|
| Immunization | 1 | 2022 | 135 | 0.180 |
Why?
|
| Inpatients | 1 | 2023 | 322 | 0.150 |
Why?
|
| Humans | 12 | 2023 | 65845 | 0.150 |
Why?
|
| Hyphae | 1 | 2018 | 17 | 0.140 |
Why?
|
| Succinate Dehydrogenase | 1 | 2018 | 16 | 0.140 |
Why?
|
| Candidiasis | 1 | 2018 | 49 | 0.140 |
Why?
|
| Candida albicans | 1 | 2018 | 61 | 0.140 |
Why?
|
| Fungal Proteins | 1 | 2018 | 153 | 0.130 |
Why?
|
| Weight Gain | 1 | 2018 | 165 | 0.130 |
Why?
|
| Obesity, Morbid | 1 | 2018 | 95 | 0.130 |
Why?
|
| Virulence | 2 | 2018 | 199 | 0.120 |
Why?
|
| Adult | 6 | 2022 | 17579 | 0.120 |
Why?
|
| Case-Control Studies | 1 | 2019 | 1148 | 0.120 |
Why?
|
| Chronic Disease | 1 | 2018 | 745 | 0.110 |
Why?
|
| Immunization Schedule | 1 | 2014 | 22 | 0.110 |
Why?
|
| Herpes Simplex | 1 | 2014 | 49 | 0.100 |
Why?
|
| Nocardia Infections | 1 | 2014 | 3 | 0.100 |
Why?
|
| Drug Resistance, Microbial | 1 | 2014 | 47 | 0.100 |
Why?
|
| Central Nervous System Infections | 1 | 2014 | 9 | 0.100 |
Why?
|
| Fusariosis | 1 | 2013 | 2 | 0.100 |
Why?
|
| Methotrexate | 1 | 2014 | 81 | 0.100 |
Why?
|
| Dermatomycoses | 1 | 2013 | 18 | 0.100 |
Why?
|
| Opportunistic Infections | 1 | 2013 | 29 | 0.100 |
Why?
|
| Pneumonia, Ventilator-Associated | 1 | 2014 | 42 | 0.100 |
Why?
|
| Immunocompromised Host | 1 | 2014 | 104 | 0.100 |
Why?
|
| Cryptococcosis | 1 | 2014 | 75 | 0.100 |
Why?
|
| Genetic Testing | 1 | 2014 | 144 | 0.100 |
Why?
|
| Gene Deletion | 1 | 2014 | 312 | 0.100 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2018 | 712 | 0.100 |
Why?
|
| Neuroaspergillosis | 1 | 2012 | 1 | 0.100 |
Why?
|
| Aspergillus | 1 | 2012 | 10 | 0.090 |
Why?
|
| Cohort Studies | 1 | 2019 | 2651 | 0.090 |
Why?
|
| Lung Diseases, Fungal | 1 | 2012 | 34 | 0.090 |
Why?
|
| Recurrence | 1 | 2014 | 665 | 0.090 |
Why?
|
| Female | 8 | 2019 | 34425 | 0.090 |
Why?
|
| Anti-Infective Agents | 1 | 2014 | 154 | 0.090 |
Why?
|
| Male | 7 | 2019 | 31410 | 0.090 |
Why?
|
| Mycoses | 1 | 2012 | 66 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 1 | 2012 | 514 | 0.080 |
Why?
|
| Phagocytosis | 1 | 2012 | 257 | 0.080 |
Why?
|
| Host-Pathogen Interactions | 1 | 2012 | 279 | 0.070 |
Why?
|
| Middle Aged | 5 | 2019 | 18501 | 0.070 |
Why?
|
| Animals | 3 | 2018 | 21493 | 0.060 |
Why?
|
| Treatment Outcome | 2 | 2014 | 5834 | 0.060 |
Why?
|
| Mice | 2 | 2018 | 11185 | 0.050 |
Why?
|
| Risk Factors | 1 | 2014 | 5475 | 0.050 |
Why?
|
| Hospitals, General | 2 | 2014 | 18 | 0.050 |
Why?
|
| Prognosis | 2 | 2014 | 1793 | 0.040 |
Why?
|
| Colony Count, Microbial | 1 | 2018 | 58 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2018 | 130 | 0.030 |
Why?
|
| California | 1 | 2018 | 178 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2018 | 238 | 0.030 |
Why?
|
| Aged | 4 | 2014 | 15147 | 0.030 |
Why?
|
| Comorbidity | 1 | 2018 | 1122 | 0.030 |
Why?
|
| Laparoscopy | 1 | 2018 | 492 | 0.030 |
Why?
|
| Fusarium | 1 | 2013 | 9 | 0.030 |
Why?
|
| Patient Outcome Assessment | 1 | 2014 | 56 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2014 | 5682 | 0.020 |
Why?
|
| Tertiary Care Centers | 1 | 2014 | 111 | 0.020 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2014 | 60 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 2500 | 0.020 |
Why?
|
| Cross Infection | 1 | 2014 | 170 | 0.020 |
Why?
|
| Drug Resistance, Fungal | 1 | 2012 | 10 | 0.020 |
Why?
|
| DNA, Fungal | 1 | 2012 | 58 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2014 | 437 | 0.020 |
Why?
|
| Mutation | 1 | 2018 | 2675 | 0.020 |
Why?
|
| Age Factors | 1 | 2014 | 1595 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2012 | 1172 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2013 | 2090 | 0.020 |
Why?
|
| Child | 1 | 2013 | 4653 | 0.010 |
Why?
|
| Young Adult | 1 | 2013 | 4883 | 0.010 |
Why?
|
| Adolescent | 1 | 2013 | 6368 | 0.010 |
Why?
|